Insider · CIK 0001466916

Byrd Scott A.

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001466916

Forms 4 and 5

Insider transactions

28 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-03-19	CADENCE PHARMACEUTICALS INCstock option (right to buy)D Disposition to Issuer	SVP, Chief Commercial Officer	DDisposition to Issuer	−70.3K sh	$10.49	−$738K	0
2014-03-19	CADENCE PHARMACEUTICALS INCrestricted stock unitD Disposition to Issuer	SVP, Chief Commercial Officer	DDisposition to Issuer	−100K sh	$14.00	−$1.4M	0
2014-03-19	CADENCE PHARMACEUTICALS INCstock option (right to buy)D Disposition to Issuer	SVP, Chief Commercial Officer	DDisposition to Issuer	−100K sh	$8.60	−$860K	0
2014-03-19	CADENCE PHARMACEUTICALS INCU Disposition from Tender	SVP, Chief Commercial Officer	UDisposition from Tender	−2,000 sh	$14.00	−$28K	0
2014-03-19	CADENCE PHARMACEUTICALS INCstock option (right to buy)D Disposition to Issuer	SVP, Chief Commercial Officer	DDisposition to Issuer	−125K sh	$3.00	−$375K	0
2014-03-19	CADENCE PHARMACEUTICALS INCstock option (right to buy)D Disposition to Issuer	SVP, Chief Commercial Officer	DDisposition to Issuer	−8,000 sh	$4.78	−$38.2K	0
2014-03-19	CADENCE PHARMACEUTICALS INCstock option (right to buy)D Disposition to Issuer	SVP, Chief Commercial Officer	DDisposition to Issuer	−240K sh	$4.78	−$1.15M	0
2014-03-19	CADENCE PHARMACEUTICALS INCstock option (right to buy)D Disposition to Issuer	SVP, Chief Commercial Officer	DDisposition to Issuer	−80K sh	$5.45	−$436K	0
2014-02-10	CADENCE PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP, Chief Commercial Officer	AAward	+100K sh	—	—	100,000
2013-12-02	CADENCE PHARMACEUTICALS INCM Exercise/Conversion	SVP, Chief Commercial Officer	MExercise/Conversion	+7,812 sh	$3.51	+$27.4K	9,812
2013-12-02	CADENCE PHARMACEUTICALS INCstock option (right to buy)M Exercise/Conversion	SVP, Chief Commercial Officer	MExercise/Conversion	−7,812 sh	—	—	70,314
2013-12-02	CADENCE PHARMACEUTICALS INCS Sale	SVP, Chief Commercial Officer	SSale	−7,812 sh	$9.16	−$71.6K	2,000
2013-11-15	CADENCE PHARMACEUTICALS INCstock option (right to buy)M Exercise/Conversion	SVP, Chief Commercial Officer	MExercise/Conversion	−10.4K sh	—	—	78,126
2013-11-15	CADENCE PHARMACEUTICALS INCM Exercise/Conversion	SVP, Chief Commercial Officer	MExercise/Conversion	+10.4K sh	$3.51	+$36.6K	12,416
2013-11-15	CADENCE PHARMACEUTICALS INCS Sale	SVP, Chief Commercial Officer	SSale	−10.4K sh	$8.00	−$83.3K	2,000
2013-06-07	CADENCE PHARMACEUTICALS INCM Exercise/Conversion	SVP, Chief Commercial Officer	MExercise/Conversion	+30.7K sh	$3.51	+$108K	32,657
2013-06-07	CADENCE PHARMACEUTICALS INCM Exercise/Conversion	SVP, Chief Commercial Officer	MExercise/Conversion	+36.5K sh	$3.51	+$128K	69,115
2013-06-07	CADENCE PHARMACEUTICALS INCS Sale	SVP, Chief Commercial Officer	SSale	−67.1K sh	$7.53	−$505K	2,000
2013-06-07	CADENCE PHARMACEUTICALS INCstock option (right to buy)M Exercise/Conversion	SVP, Chief Commercial Officer	MExercise/Conversion	−30.7K sh	—	—	0
2013-06-07	CADENCE PHARMACEUTICALS INCstock option (right to buy)M Exercise/Conversion	SVP, Chief Commercial Officer	MExercise/Conversion	−36.5K sh	—	—	88,542
2013-03-13	CADENCE PHARMACEUTICALS INCStock option (right to buy)A Award	SVP, Chief Commercial Officer	AAward	+100K sh	—	—	100,000
2012-03-14	CADENCE PHARMACEUTICALS INCstock option (right to buy)A Award	SVP, Chief Commercial Officer	AAward	+125K sh	—	—	125,000
2012-03-14	CADENCE PHARMACEUTICALS INCstock option (right to buy)A Award	SVP, Chief Commercial Officer	AAward	+30.7K sh	—	—	30,657
2011-05-10	CADENCE PHARMACEUTICALS INCP Purchase	SVP, Chief Commercial Officer	PPurchase	+2,000 sh	$7.22	+$14.4K	2,000
2011-03-16	CADENCE PHARMACEUTICALS INCStock option (right to buy)A Award	SVP, Chief Commercial Officer	AAward	+80K sh	—	—	80,000
2010-03-25	CADENCE PHARMACEUTICALS INCStock option (right to buy)A Award	SVP, Chief Commercial Officer	AAward	+240K sh	—	—	240,000
2010-03-25	CADENCE PHARMACEUTICALS INCStock option (right to buy)A Award	SVP, Chief Commercial Officer	AAward	+8,000 sh	—	—	248,000
2009-07-15	CADENCE PHARMACEUTICALS INCStock option (right to buy)A Award	SVP, Chief Commercial Officer	AAward	+125K sh	—	—	125,000

Recent filings

Accepted (ET)
Mar 214
CADENCE PHARMACEUTICALS INC0001209191-14-022390
SEC(opens sec.gov)
Feb 124
CADENCE PHARMACEUTICALS INC0001209191-14-009660
SEC(opens sec.gov)
Dec 34
CADENCE PHARMACEUTICALS INC0001209191-13-055053
SEC(opens sec.gov)
Nov 184
CADENCE PHARMACEUTICALS INC0001209191-13-052925
SEC(opens sec.gov)
Jun 114
CADENCE PHARMACEUTICALS INC0001209191-13-031639
SEC(opens sec.gov)

Companies

CADENCE PHARMACEUTICALS INCSVP, Chief Commercial Officer

Address

C/O CADENCE PHARMACEUTICALS, INC. 12481 HIGH BLUFF DRIVE, STE 200

SAN DIEGO, CA, 92130